Cargando…
Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy
SIMPLE SUMMARY: Chimeric antigen receptor (CAR)-T cell therapy has been highly successful in treating hematological malignancies like leukemia and lymphoma, leading to advancements in immunotherapy. The approval of anti-CD19 CAR-T cells by the FDA in 2017 has paved the way for CAR-T therapies to be...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10340266/ https://www.ncbi.nlm.nih.gov/pubmed/37444586 http://dx.doi.org/10.3390/cancers15133476 |